HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 56 filers reported holding HOOKIPA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $924 | -30.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,320 | +19.6% | 1,500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,104 | -9.1% | 1,500 | 0.0% | 0.00% | – |
| Q4 2022 | $1,215 | -39.2% | 1,500 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -66.7% | 1,500 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -35.7% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | -30.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | +150.0% | 1,500 | +100.0% | 0.00% | – |
| Q4 2020 | $8,000 | +14.3% | 750 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 750 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 750 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 300,000 | $220,800 | 0.34% |
| Redmile Group, LLC | 2,552,949 | $1,878,970 | 0.08% |
| Artal Group S.A. | 1,849,616 | $1,361 | 0.08% |
| EcoR1 Capital, LLC | 2,473,489 | $1,820,488 | 0.06% |
| Baker Brothers Advisors | 3,475,535 | $2,557,994 | 0.01% |
| Leucadia National | 1,015,211 | $747,195 | 0.01% |
| Virtu Financial LLC | 62,308 | $46 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 177,600 | $130,714 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 682,349 | $500 | 0.00% |
| Alyeska Investment Group, L.P. | 126,779 | $93,309 | 0.00% |